← Database
M&A

SOC TELEMED

Acquired by

PATIENT SQUARE CAPITAL

UNITED STATES Software / Industry-Specific Software / Healthcare EV 100m USD - 500m USD 04/2022

Target

SOC TELEMED

Acquirer

PATIENT SQUARE CAPITAL

Context

SOC Telemed completed its acquisition by Patient Square Capital. The strategic rationale is rooted in SOC Telemed’s position as the largest national provider of acute‑care telemedicine in the US, with a scalable enterprise platform, Telemed IQ, and a diverse portfolio of specialty telemedicine services. For Patient Square, the acquisition aligns with a broader thesis of backing capital‑efficient, high‑margin, technology‑enabled healthcare solutions that can standardize and scale virtual care delivery across hospital and health‑system clients. The sponsor’s backing provides SOC Telemed with enhanced capital flexibility to invest in clinical capabilities, product innovation, and geographic expansion while maintaining its existing leadership under Chief Executive Officer Dr. Chris Gallagher.

SOC TELEMED, which reported an EBITDA margin of LOGIN in 2022, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (13.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

SOC Telemed, Inc. is a leading national provider of acute care telemedicine technology and solutions, headquartered in Herndon, Virginia. Since 2004, the company has delivered virtual care programs across a broad range of clinical specialties for hospitals, health systems, post‑acute providers, physician networks, and value‑based care organizations. Its enterprise platform, Telemed IQ, is designed to rapidly deploy and centrally manage telemedicine services across the continuum of care, enabling clients to scale programs with minimal operational friction. The company’s business model centers on B2B telemedicine infrastructure and program management, combining technology licensing, professional services, and ongoing support. SOC Telemed offers multiple clinical service lines, including teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, and teleMaternal‑Fetal Medicine, making it one of the most comprehensive acute‑telemedicine vendors in the US. The platform’s enterprise‑grade architecture supports standardization, regulatory compliance, and integration with existing hospital workflows.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2022
LOGIN
LOGIN
LOGIN
2021
LOGIN
LOGIN
LOGIN

Other operations with SOC TELEMED

REFERENCES

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Acquirer: patient square capital